Does ALEMTUZUMAB Cause Immunodeficiency? 114 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 114 reports of Immunodeficiency have been filed in association with ALEMTUZUMAB (Campath). This represents 0.8% of all adverse event reports for ALEMTUZUMAB.
114
Reports of Immunodeficiency with ALEMTUZUMAB
0.8%
of all ALEMTUZUMAB reports
3
Deaths
41
Hospitalizations
How Dangerous Is Immunodeficiency From ALEMTUZUMAB?
Of the 114 reports, 3 (2.6%) resulted in death, 41 (36.0%) required hospitalization, and 5 (4.4%) were considered life-threatening.
Is Immunodeficiency Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 114 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Immunodeficiency?
ADALIMUMAB (2,981)
RITUXIMAB (1,256)
TOCILIZUMAB (1,061)
ABATACEPT (1,042)
METHOTREXATE (926)
ETANERCEPT (799)
INFLIXIMAB (693)
CETIRIZINE (650)
METHYLPREDNISOLONE (615)
ALBUTEROL (599)
Which ALEMTUZUMAB Alternatives Have Lower Immunodeficiency Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET